2020.07.09 02:20
No. | Subject | Date | Author | Last Update | Views |
---|---|---|---|---|---|
Notice | How to write your comments onto a webpage [2] | 2016.07.06 | 운영자 | 2016.11.20 | 17771 |
Notice | How to Upload Pictures in webpages | 2016.07.06 | 운영자 | 2018.10.19 | 31855 |
Notice | How to use Rich Text Editor [3] | 2016.06.28 | 운영자 | 2018.10.19 | 5498 |
Notice | How to Write a Webpage | 2016.06.28 | 운영자 | 2020.12.23 | 43428 |
8832 | 돌아오는 기러기 [1] | 2024.03.27 | 정관호*63 | 2024.03.28 | 16 |
8831 | 이강인-손흥민 ‘골 합작’ 한국, 태국 3-0 완승…월드컵 최종 예선 진출 성큼 [2] | 2024.03.26 | 황규정*65 | 2024.03.27 | 10 |
8830 | 1945년 8월 15일 오후 강릉 홍제정 안마을에서 [2] | 2024.03.19 | 정관호*63 | 2024.03.24 | 57 |
8829 | 이승만은 왜 김구를 제거 했을까? [1] | 2024.03.17 | 온기철*71 | 2024.03.18 | 35 |
8828 | My Grandson [1] | 2024.03.15 | 노영일*68 | 2024.03.18 | 77 |
8827 | 蜀相(촉상): 촉한 승상 제갈량 [1] | 2024.03.15 | 정관호*63 | 2024.03.15 | 34 |
8826 | 1945년 8월15일에는 서울에 아무일도 없었다. [1] | 2024.03.13 | 온기철*71 | 2024.03.14 | 34 |
8825 | 왕소군 고향에서 [1] | 2024.03.08 | 정관호*63 | 2024.03.20 | 37 |
8824 | 정약용; 늙어가면 친구가 점점 없어진다. [5] | 2024.03.06 | 온기철*71 | 2024.03.08 | 65 |
8823 | Trump is OK to be a candidate. | 2024.03.04 | 온기철*71 | 2024.03.17 | 46 |
8822 | AMAZING GRACE [1] | 2024.03.01 | 정관호*63 | 2024.03.08 | 50 |
8821 | 한국에의 복수국적 - 이중국적이 더 불리한 경우를 알려 드립니다 [1] | 2024.02.24 | 운영자 | 2024.02.24 | 67 |
8820 | 신진서, 농심배 16연승... 중국 기사 올킬로 한국 4연속 우승 [1] | 2024.02.23 | 황규정*65 | 2024.02.23 | 39 |
8819 | 古朝鮮:고조선 [1] | 2024.02.23 | 정관호*63 | 2024.02.26 | 41 |
8818 | 한국진공작전; Eagle Project and Napko Project [2] | 2024.02.22 | 온기철*71 | 2024.02.28 | 87 |
8817 | 일제의 김구 암살 공작과 밀정 [2] | 2024.02.19 | 온기철*71 | 2024.02.22 | 73 |
8816 | 장개석은 한국에 친중정부가 수립 되게 하려고 임정을 도왔다. [1] | 2024.02.17 | 온기철*71 | 2024.02.24 | 80 |
8815 | 봄날의 원망 [1] | 2024.02.16 | 정관호*63 | 2024.02.16 | 36 |
8814 | 내 마음은 가을 달 [1] | 2024.02.08 | 정관호*63 | 2024.02.14 | 470 |
8813 | 1945년8월15일은 과연 해방이었을까? [2] | 2024.02.06 | 온기철*71 | 2024.02.07 | 62 |
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
List of authors.
Abstract
BACKGROUND
Baloxavir marboxil (baloxavir) is a polymerase acidic protein (PA) endonuclease inhibitor with clinical efficacy in the treatment of uncomplicated influenza, including in outpatients at increased risk for complications. The postexposure prophylactic efficacy of baloxavir in the household setting is unclear.
METHODS
We conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the postexposure prophylactic efficacy of baloxavir in household contacts of index patients with confirmed influenza during the 2018–2019 season in Japan. The participants were assigned in a 1:1 ratio to receive either a single dose of baloxavir or placebo. The primary end point was clinical influenza, as confirmed by reverse-transcriptase–polymerase-chain-reaction testing, over a period of 10 days. The occurrence of baloxavir-selected PA substitutions associated with reduced susceptibility was assessed.
RESULTS
A total of 752 household contacts of 545 index patients were randomly assigned to receive baloxavir or placebo. Among the index patients, 95.6% had influenza A virus infection, 73.6% were younger than 12 years of age, and 52.7% received baloxavir. Among the participants who could be evaluated (374 in the baloxavir group and 375 in the placebo group), the percentage in whom clinical influenza developed was significantly lower in the baloxavir group than in the placebo group (1.9% vs. 13.6%) (adjusted risk ratio, 0.14; 95% confidence interval [CI], 0.06 to 0.30; P<0.001). Baloxavir was effective in high-risk, pediatric, and unvaccinated subgroups of participants. The risk of influenza infection, regardless of symptoms, was lower with baloxavir than with placebo (adjusted risk ratio, 0.43; 95% CI, 0.32 to 0.58). The incidence of adverse events was similar in the two groups (22.2% in the baloxavir group and 20.5% in the placebo group). In the baloxavir group, the viral PA substitutions I38T/M or E23K were detected in 10 (2.7%) and 5 (1.3%) participants, respectively. No transmission of these variants from baloxavir-treated index patients to participants in the placebo group was detected; however, several instances of transmission to participants in the baloxavir group could not be ruled out.
CONCLUSIONS
Single-dose baloxavir showed significant postexposure prophylactic efficacy in preventing influenza in household contacts of patients with influenza. (Funded by Shionogi; Japan Primary Registries Network number, JapicCTI-184180.)(NEJM July 8, 2020)